AMGN vs VLTO · P/E 24, rev $10.05B vs P/E 29, rev $5.50B
Amgen Inc (AMGN) versus Veralto Corporation (VLTO) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Veralto Corporation (VLTO) is a pollution & treatment controls company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported VLTO revenue for 2025-12-31 was $5.50B. Net income was $940.0M. Revenue was up 6.0% from 2024-12-31 to 2025-12-31. VLTO currently screens at market cap $25.26B and trailing P/E 29.1.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. VLTO currently screens at market cap $25.26B and trailing P/E 29.1.
Not investment advice. Open the AMGN and VLTO stock pages for the full models.
Not investment advice.